CCNF Protein (Cyclin F)

Overview

Ccnf Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Cyclin F (encoded by the CCNF gene) is a unique member of the cyclin family that functions as the substrate recognition component of SCF (Skp1-Cul1-F-box) ubiquitin ligase complexes. Unlike other cyclins that regulate cell cycle checkpoints, Cyclin F is primarily involved in protein quality control and cellular homeostasis, making it critically important in neurodegenerative diseases.

Structure

Cyclin F contains several key structural features:

• F-box Domain (aa 1-47): Mediates interaction with Skp1 and Cul1 to form the SCF ubiquitin ligase complex

• Cyclin Box Domain (aa 51-165): Binds to substrate proteins for ubiquitination

• C-terminal Dimerization Region: Allows formation of functional dimers

• Nuclear Localization Signal (NLS): Facilitates nuclear import

The F-box architecture allows CCNF to assemble into SCF^CCNF^ ubiquitin ligase complexes that target specific proteins for proteasomal degradation.

Normal Function

Ubiquitin Ligase Activity

Cyclin F functions as an E3 ubiquitin ligase:

• SCF Complex Formation: Forms SCF^CCNF^ ubiquitin ligase complex with Skp1 and Cul1

• Substrate Recognition: Binds specific substrates via cyclin box domain

• Polyubiquitination: Targets substrates for proteasomal degradation via K48-linked chains

Key Substrates

• FBXL5: Iron metabolism regulator - CCNF-mediated degradation affects cellular iron homeostasis

• CDC25A/B: Cell cycle phosphatases - controls G1/S transition

• RPAP3: RNA polymerase II assembly factor

• GTF2E1: General transcription factor

Cellular Functions

• Cell Cycle Regulation: Controls G1/S transition through CDC25 degradation

• DNA Damage Response: Regulates repair proteins including Cdk inhibitors

• Iron Metabolism: FBXL5 degradation via CCNF affects iron homeostasis

• Protein Quality Control: Clearance of damaged or misfolded proteins

• Transcriptional Regulation: Modulates RNA polymerase II function

Role in Disease

Amyotrophic Lateral Sclerosis (ALS)

CCNF mutations are a significant cause of familial ALS and FTD:

• Loss-of-function mutations reduce degradation of aggregation-prone proteins

• Impaired clearance of TDP-43 leading to cytoplasmic accumulation in motor neurons

• Dysregulated protein homeostasis leads to endoplasmic reticulum stress

• Motor neuron-specific vulnerability due to impaired proteostasis

Frontotemporal Dementia (FTD)

CCNF mutations cause FTD through similar mechanisms:

• Ubiquitin system dysfunction impairs protein clearance

• TDP-43 pathology in frontal/temporal cortices

• Progressive loss of cortical neurons in affected brain regions

Disease Mechanisms

Therapeutic Targeting

Current therapeutic approaches under investigation:

• Protein Aggregation Modulators: Enhance protein clearance via autophagy

• Ubiquitin System Enhancers: Boost SCF^CCNF^ activity

• Gene Therapy: Viral vector delivery of wild-type CCNF

• Small Molecule Enhancers: Compounds that restore CCNF function

• Protein Replacement: Exogenous protein delivery

Expression in Brain

Cyclin F is expressed in various brain cell types:

• Neurons: Moderate expression in cortical and motor neurons

• Astrocytes: Lower expression levels

• Microglia: Constitutive expression for immune surveillance

Animal Models

Mouse models with CCNF mutations show:

• Motor neuron degeneration

• TDP-43 pathology

• Impaired protein clearance

• Progressive motor deficits

Key Publications

1. Williams KL et al. (2016) CCNF mutations in ALS/FTD. Nat Neurosci.

2. Zhang Y et al. (2019) Cyclin F structure and function. Cell.

3. Hogan AL et al. (2021) Cyclin F and protein homeostasis in neurodegenerative disease. Brain.

Molecular Mechanisms

SCF^CCNF^ Ubiquitin Ligase Complex

The SCF (Skp1-Cul1-F-box) ubiquitin ligase complex is a multicomponent E3 ubiquitin ligase system that mediates substrate ubiquitination. CCNF (Cyclin F) serves as the F-box protein substrate recognition component:

flowchart TD
    A["CCNF\nF-box protein"] -->|"Binds"| B["Skp1"]
    B -->|"Links"| C["Cul1 scaffold"]
    C -->|"Recruits"| D["E2 ubiquitin-conjugating enzyme"]
    D -->|"Transfers"| E["Ubiquitin chain"]
    E -->|"Targets"| F["Substrate protein"]
    F -->|"Leading to"| G["Proteasomal degradation"]

    S1["FBXL5"] -.->|"Substrate"| F
    S2["CDC25A/B"] -.->|"Substrate"| F
    S3["RPAP3"] -.->|"Substrate"| F
    S4["GTF2E1"] -.->|"Substrate"| F

Substrate Recognition and Degradation

The cyclin box domain of CCNF recognizes specific degron sequences on substrate proteins. Key substrates include:

Protein Homeostasis in Neurodegeneration

The loss of CCNF function in ALS/FTD leads to disrupted proteostasis through multiple mechanisms:

1. Accumulation of aggregation-prone proteins: Reduced degradation of misfolded proteins

2. Impaired clearance of TDP-43: TDP-43 aggregates accumulate in cytoplasm

3. ER stress induction: Accumulation of misfolded proteins triggers UPR

4. Mitochondrial dysfunction: Iron homeostasis disruption affects mitochondrial function

flowchart LR
    subgraph Normal
        A["CCNF functional"] --> B["SCF complex"]
        B --> C["Proper ubiquitination"]
        C --> D["Proteasomal clearance"]
    end

    subgraph Disease
        E["CCNF mutation"] --> F["Impaired E3 ligase"]
        F --> G["Substrate accumulation"]
        G --> H["Protein aggregation"]
        H --> I["ER stress"]
        H --> J["Apoptosis"]
    end

Therapeutic Targeting

Current therapeutic approaches under investigation:

• Protein Aggregation Modulators: Enhance protein clearance via autophagy

• Ubiquitin System Enhancers: Boost SCF^CCNF^ activity

• Gene Therapy: Viral vector delivery of wild-type CCNF

• Small Molecule Enhancers: Compounds that restore CCNF function

• Protein Replacement: Exogenous protein delivery

Preclinical Approaches

Expression in Brain

Cyclin F is expressed in various brain cell types:

• Neurons: Moderate expression in cortical and motor neurons

• Astrocytes: Lower expression levels

• Microglia: Constitutive expression for immune surveillance

Cell Type-Specific Vulnerability

Motor neurons in ALS show particular vulnerability to CCNF mutations due to:

• High protein turnover requirements

• Long axonal projections requiring efficient transport

• High metabolic demands

• Specialized proteostasis mechanisms

Animal Models

Mouse models with CCNF mutations show:

• Motor neuron degeneration

• TDP-43 pathology

• Impaired protein clearance

• Progressive motor deficits

Zebrafish Models

Zebrafish knockdown models demonstrate:

• Motor axon guidance defects

• Swimming abnormalities

• TDP-43 aggregation

• Rescue with wild-type CCNF mRNA

See Also

• CCNF Gene

• Amyotrophic Lateral Sclerosis

• Frontotemporal Dementia

• SCF Ubiquitin Ligase

• Protein Degradation

• TDP-43 Protein